|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-2-10
|
|
pubmed:abstractText |
In recent large cardiovascular trials done in stable patients, 14-31% of the participants were smokers; the consequences of smoking in these trials using medications known to reduce cardiovascular events, have not been assessed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1741-8267
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
75-81
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15703510-Aged,
pubmed-meshheading:15703510-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:15703510-Antioxidants,
pubmed-meshheading:15703510-Cardiovascular Diseases,
pubmed-meshheading:15703510-Female,
pubmed-meshheading:15703510-Humans,
pubmed-meshheading:15703510-Incidence,
pubmed-meshheading:15703510-Male,
pubmed-meshheading:15703510-Middle Aged,
pubmed-meshheading:15703510-Morbidity,
pubmed-meshheading:15703510-Myocardial Infarction,
pubmed-meshheading:15703510-Preventive Medicine,
pubmed-meshheading:15703510-Ramipril,
pubmed-meshheading:15703510-Risk Factors,
pubmed-meshheading:15703510-Smoking,
pubmed-meshheading:15703510-Stroke,
pubmed-meshheading:15703510-Treatment Outcome,
pubmed-meshheading:15703510-Vitamin E
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial.
|
|
pubmed:affiliation |
Laval University Heart and Lung Institute, Ste-Foy, Quebec G1V 4G5, Canada. Gilles.Dagenais@crhl.ulaval.ca
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
